Related Experiment Video
Updated: Mar 22, 2026

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
Published on: July 24, 2019
Technology in Parkinson's disease: Challenges and opportunities
Alberto J Espay1, Paolo Bonato2, Fatta B Nahab3
1James J. and Joan A. Gardner Family Center for Parkinson's disease and Movement Disorders, University of Cincinnati, Cincinnati, Ohio, USA. alberto.espay@uc.edu.
Advanced technologies offer new ways to study Parkinson's disease (PD), but challenges remain in data integration and clinical application. Developing open-source platforms for personalized treatment is key to improving patient care and quality of life.
Area of Science:
- Neurology
- Biomedical Engineering
- Digital Health
Background:
- Technological advancements enable unprecedented data capture in Parkinson's disease (PD).
- Current data integration and application face challenges, hindering a deeper understanding of PD complexity.
- Existing technology platforms are often incompatible, and widespread sensor deployment is difficult, especially in elderly populations.
Purpose of the Study:
- To identify challenges and opportunities in developing advanced technologies for Parkinson's disease management.
- To promote the development of integrated measurement and closed-loop therapeutic systems.
- To enhance clinical management and improve the quality of life for individuals with PD.
Main Methods:
- Convening a task force of engineers, clinicians, researchers, and patients.
- Summarizing work on identifying technological challenges and opportunities in PD.
- Focusing on developing integrated measurement and closed-loop therapeutic systems.
Main Results:
- Identified key challenges: incompatible platforms, large-scale sensor deployment, and the gap between big data and clinical application.
- Highlighted opportunities: open-source platforms for multichannel data capture and adaptable, individualized treatment systems.
- Emphasized the need for technologies supporting phenotyping, early detection, tailored therapy, subgroup targeting, and biomarker identification.
Conclusions:
- Open-source and adaptable technologies are crucial for advancing Parkinson's disease research and care.
- Integrated measurement and closed-loop systems can improve early detection, symptomatic therapy, and treatment targeting.
- Technological development should focus on creating objective biomarkers for longitudinal tracking and enhancing patient adherence and quality of life.
More Related Videos
06:32Author Spotlight: Automated Deep Brain Stimulation for Parkinson's Disease - Exploring the Possibilities and Challenges of Home Monitoring
Published on: July 14, 2023
08:36The Immersive Cleveland Clinic Virtual Reality Shopping Platform for the Assessment of Instrumental Activities of Daily Living
Published on: July 28, 2022
Related Concept Videos
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease: Overview
Alzheimer's Disease: Treatment